Motor neurone disease strikes without warning, often in people at the peak of physical fitness. Yet diagnosis remains frustratingly slow, and treatment options remain limited.
Motor neurone disease, also called ALS or Lou Gehrig's disease in the United States, destroys nerve cells that control voluntary muscle movement. Patients experience progressive weakness, muscle wasting, and eventually paralysis. The disease kills most patients within two to five years of symptom onset.
Diagnosis delays stem from several factors. Early symptoms mimic other conditions. Muscle weakness, slurred speech, or difficulty swallowing can suggest thyroid problems, Lyme disease, or stroke. Neurologists must rule out these alternatives through blood tests, imaging, and electromyography before confirming motor neurone disease. This process takes months or even years.
The disease affects both famous and ordinary people. Stephen Hawking lived with ALS for decades, an unusual case. Most patients face rapid decline.
Current treatment offers modest benefit. Riluzole, an FDA-approved medication, extends life by a few months on average. Edaravone, approved more recently, slows progression slightly in some patients. Neither reverses damage. No cure exists.
Research continues into disease mechanisms. Scientists study genetic mutations, protein buildup in nerve cells, and inflammation. These investigations may yield better diagnostics and treatments. Earlier diagnosis becomes increasingly important as new therapies emerge, even if they only slow progression.
The disease's randomness makes prevention impossible. Age, genetics, and environmental factors all play roles, but no clear prevention strategy exists. Young, healthy athletes develop the condition. So do elderly people.
Patients and families face difficult decisions quickly. Without a cure, treatment planning focuses on quality of life and symptom management. Speech therapy, physical therapy, and assistive devices help maintain function as long as possible. Ventilators eventually become necessary for